|
Alimta |
Details
|
Alimta is the only chemotherapy agent approved by the Food and Drug Administration in treatment of malignant pleural mesothelioma when surgery is not an option. Chemotherapy is a treatment procedure with one or more anti-cancer drugs used to destroy cancer cells. Alimta stops the production of three enzymes which require to feed the cancel cell and works by interfering with a process that is crucial that allows cancer cells to spread or reproduce. MPM (malignant pleural mesothelioma) is a cancer of the linings of the lungs. When compared to Cisplatin, a large clinical study showed that Alimta improved the survival rate for patients with this rare cancer. Patients on the drug shown to survive approx. three months longer than patients who received only Cisplatin. Side effects of this medication range from mild to moderate. Call 1-800-545-5978 for more information.
|
| Category |
Drugs and Medicine > A
|
| Related Searches |
alimta mesothelioma pemetrexed treatment, lung cancer |
| Date Submitted |
23-Jul-2005
|
|
